Education
About Us
Working with TipRanks
Follow Us
Hangzhou Tigermed Consulting Co., Ltd. Class H (DE:5HZ1)
FRANKFURT:5HZ1
RESEARCH TOOLSreports
Comparison Results
Hangzhou Tigermed Consulting Co., Ltd. Class H
€4.10
€4.49B
80.49
12.97%
3 Buy
0 Hold
1 Sell
Moderate Buy
Sino Biopharmaceutical
$0.64
$11.37B
46.87
93.03%
2 Buy
0 Hold
0 Sell
Moderate Buy
CSPC Pharmaceutical Group
$1.05
$11.15B
20.51
34.62%
5 Buy
2 Hold
1 Sell
Moderate Buy
Shanghai Fosun Pharmaceutical (Group) Co
$1.96
$8.45B
12.84
15.00%
0 Buy
1 Hold
0 Sell
Hold
Wuxi Biologics (Cayman)
$3.25
$12.49B
28.61
113.82%
7 Buy
2 Hold
0 Sell
Strong Buy
Performance Comparison
DE:5HZ1
Hangzhou Tigermed Consulting Co., Ltd. Class H
3.92
0.47
13.62%
SBMFF
Sino Biopharmaceutical
0.64
0.31
93.94%
CHJTF
CSPC Pharmaceutical Group
1.05
0.27
34.62%
LVZPF
Livzon Pharmaceutical Group
3.65
0.57
18.51%
SFOSF
Shanghai Fosun Pharmaceutical (Group) Co
1.96
0.26
15.29%
WXIBF
Wuxi Biologics (Cayman)
3.25
1.87
135.51%